Priced like the old business, running like a new one: management is redirecting the call away from the metric investors
The model's full reasoning — Q4 2016 call → NO我们根据提供的财报电话会议记录,判断管理层是否反复将注意力从公司通常被评判的指标或叙事上转移开,并转向一个已经盈利的不同业务部分,同时表明记录尚未跟上。 分析电话会议内容: - 公司是百时美施贵宝(Bristol-Myers Squibb),主要关注免疫肿瘤学(I-O),特别是Opdivo和Yervoy。 - 传统评判标准可能是Opdivo在肺癌领域的销售和市场份额,尤其是与默克(Merck)的Keytruda竞争。 - 管理层确实讨论了肺癌方面的挑战,但反复强调更广泛的I-O项目、其他适应症(如肾癌、黑色素瘤、头颈癌)以及国际业务。 - 他们提到“美国非肺癌业务”和“国际业务”是增长领域。 - 然而,他们并没有明确说传统指标(如Opdivo总销售额或肺癌市场份额)不再是正确的衡量标准。他们仍然在讨论Opdivo的销售和市场份额,只是将其分解为不同部分。 - 他们确实指出,美国肺癌业务面临压力,但非肺癌业务和国际业务正在增长。但他们并没有说这些新部分已经“盈利”而传统部分没有;他们只是说增长来自这些领域。 - 他们也没有明确表示记录尚未跟上,即这些新部分尚未反映在结果中。实际上,他们给出了2017年的指导,并讨论了这些部分的预期增长。 - 管理层没有将传统指标(如Opdivo总销售额)视为过时,而是将其分解并讨论各个部分。 - 他们确实提到了“我们相信通过我们广泛的开发项目,我们有机会在第一线肺癌治疗中发挥重要作用”,但这是关于未来潜力的,不是关于已经盈利的。 - 关于“已经盈利”的部分,他们提到了国际业务和美国的非肺癌业务,这些已经在产生收入。但他们并没有说这些是“不同的部分”,而是说它们是Opdivo业务的一部分。 - 他们也没有说记录尚未跟上;他们给出了2017年的指导,并讨论了这些部分的预期增长。 总体而言,管理层是在讨论Opdivo业务的不同组成部分,并强调增长领域,但并没有明确将传统指标(如Opdivo总销售额或肺癌市场份额)视为过时,也没有明确说有一个不同的部分已经盈利而记录尚未反映。他们是在正常讨论业务,尽管面临挑战,但并没有改变评判标准。 因此,答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| NOAH | Noah Holdings Limited | Q1 2024 | 2024-05-30 | D |
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| OPAD | Offerpad Solutions Inc. | Q3 2023 | 2023-11-01 | C |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CALX | Calix, Inc. | Q1 2023 | 2023-04-20 | C+ |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| LC | LendingClub Corporation | Q4 2021 | 2022-01-26 | A |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| LOB | Live Oak Bancshares, Inc. | Q3 2018 | 2018-10-25 | C+ |
SPT · Q2 2023 → YESThe question is whether management repeatedly redirects attention away from the conventional measure toward a different part of the business that's already earning today, and indicates that this diffe...YES The transcript shows management repeatedly reframing away from the conventional total ARR/revenue growth metric (which is being distorted by unpredictable low-end non-core ARR) toward the higher-quality up-market/enterprise segment that is already delivering record new business ACVs, 50%+ YoY growth, and 43% of 2023 ARR. They explicitly set the low-end aside by removing it from forecasts and modeling to give “greatest visibility,” note that Q2 ARR growth will be the lowest pace of the year because of this change, and indicate the reported figures still reflect the old mix while the new up-market story is already earning today (with Tagger adding further upside not yet reflected). This creates the coherent posture of redirecting attention from the headline growth number outsiders watch to the part of the business that is already producing real results.
WD · Q2 2022 → YESThe question is about whether management repeatedly redirects attention away from the conventional measure to a different part of the business that's already earning today, and indicates that this isn...YES The transcript shows management repeatedly reframing the discussion away from the conventional multifamily agency lender yardstick (origination volumes, GSE lending, MSR-driven EPS) toward the diversified services and asset-management businesses that are already generating substantial cash revenue and EBITDA today. They explicitly set the old metric aside by introducing adjusted EPS to “strip out non-cash mortgage servicing rights,” highlight the shift from “lending-centric” to “broader technology-enabled financial services,” and note that segment results now provide “more transparency into our operating structure.” They point to debt brokerage, property sales, SAM (Alliant, Zelman), small-balance lending, and appraisals as the new earning engines, describing their concrete contributions (e.g.
CALX · Q1 2023 → YESThe question is about whether management repeatedly redirects attention away from the conventional measure to a different part of the business that's already earning today, and indicates that this isn...YES The transcript shows management repeatedly framing the company as operating in a "new market" centered on platforms, clouds, and managed services—distinct from the legacy hardware/cyclical model—while highlighting real earnings from these areas (e.g., 988 BSPs deploying platforms, 865 cloud customers, 334 with 41 new managed services in Q1, record Intelligent Access EDGE revenue). They indicate this is already producing revenue and customer adoption but remains early-stage ("this is the beginning," "early stage of where we are in this new market"), with reported results still reflecting the prior hardware-focused picture.